See other companies on Otta
Entia
Medical devices that enable treatment from cancer patients' homes
- 21-100 employees
- Healthcare
- B2B
- Personal health
- Data Integration
- MedTech
- 60 Grays Inn Road, WC1X 8LU, London, United Kingdom
Jump to section
Company mission
To build solutions that give cancer patients more quality time than any alternative.
Otta's take
Theo Margolius
COO of Otta
Entia have developed a hand-held blood testing kit that can be used at home by chemotherapy patients to tailor treatment to their specific needs.
Its monitor can reduce cancellations for chemotherapy appointments and limit hospital visits just for blood count checks. And that means there are more chemotherapy slots for other people awaiting urgent treatment.
Using the monitor not only ensures that clinical pathways are fashioned around the individual’s needs but it also achieves a significant reduction in healthcare spending.
After forming a partnership with Pfizer UK and using some of its latest funding on creating Entia Liberty - the virtual oncology solution, the company is focused on offering virtual monitoring service being made available in the UK for metastatic breast cancer patients, pending the usual regulatory approval.
Benefits
- Collaborations with world-leading research institutions, healthcare providers and companies
- We give you the tools and the tech you need to get you going
- A fun and collaborative environment where you get to join a growing start-up transforming the delivery of cancer care
- Annual company trip as well as regular company events, hack days and social actives
- 43 days of annual leave (30 days flexible leave, 8 bank holidays allowance taken whenever you like and 5 days of company shutdown at the end of each year), plus volunteering days & sabbatical opportunities
- A flexible work environment - our culture is built on trust
- Perks and benefits including corp discounts, cycle to work, pension, and personal support including mental health and financial advice. We're currently working through these to add more and make them even better!
- Annual training budget
- Professional development and career progression - we want you to achieve your greatest potential here
- Collaborations with world-leading research institutions, healthcare providers and companies
Funding (last 2 of 5 rounds)
Jul 2023
$20m
SERIES A
Oct 2021
$12m
EARLY VC
$35.6m
Total funding
This company has top investors
Founders
Toby Basey-Fisher
(CEO)Previously Enterprise Fellow at Imperial College London.
People progressing
Joined as an Engineer, promoted to Head of Innovation after 20 months, then again to CTO after 7 months.